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Abstract
Lung cancer is the leading cause of cancer mortality in Mexico and worldwide. In the past decade, there has been an
increase in the number of lung cancer cases in young people, which suggests an important role for genetic back-
ground in the etiology of this disease. In this study, we genetically characterized 16 polymorphisms in 12 low
penetrance genes (AhR, CYP1A1, CYP2E1, EPHX1, GSTM1, GSTT1, GSTPI, XRCC1, ERCC2, MGMT, CCND1
and TP53) in 382 healthy Mexican Mestizos as the first step in elucidating the genetic structure of this population and
identifying high risk individuals. All of the genotypes analyzed were in Hardy-Weinberg equilibrium, but different de-
grees of linkage were observed for polymorphisms in the CYP1A1 and EPHX1 genes. The genetic variability of this
population was distributed in six clusters that were defined based on their genetic characteristics. The use of a
polygenic model to assess the additive effect of low penetrance risk alleles identified combinations of risk genotypes
that could be useful in predicting a predisposition to lung cancer. Estimation of the level of genetic susceptibility
showed that the individual calculated risk value (iCRV) ranged from 1 to 16, with a higher iCRV indicating a greater
genetic susceptibility to lung cancer.
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Introduction
Lung cancer (LC) is the major cause of mortality
from neoplasias worldwide. In Mexico, LC was responsi-
ble for 11.45% of deaths by malignant neoplasia from
1998-2002,andaprospectivestudyindicatedthatmortality
from LC will be even greater in the future (Ruíz-Godoy et
al., 2007). Lung cancer is a serious public health problem
(Proctor, 2001). The World Health Organization (WHO)
estimates that in 2030 the number of deaths attributable to
the consumption of tobacco will be 100 million, accompa-
nied by an increased incidence of LC (Xie and Minna,
2008).
Lung cancer is highly related to tobacco consump-
tion, although only 20% of smokers develop LC. On other
hand,thenumberofcasesamongpeopleunder50yearsold
hasincreased(Gemignanietal.,2007),highlightingtheim-
portance of genetic background in the etiology of LC. In
this context, efforts have been made to identify polymor-
phisms associated with the risk of developing LC. Associa-
tion studies have focused mainly on polymorphisms in
genes coding for (1) enzymes involved in the bioactivation
of carcinogens, such as cytochromes P450 CYP1A1 (Shah
et al., 2008), CYP2E1 (Zhan et al., 2010) and CYP2D6
(Shawetal.,1998),(2)enzymesinvolvedindetoxification,
e.g., glutathione transferases GSTM1, GSTT1 and GSTP1
(Sobti et al., 2008), N-acetyl transferase 2 (NAT2) and
epoxide hydrolase (EPHX1) (Zhou et al., 2002), (3) pro-
teins involved in DNA repair, such as XRCC1, XRCC3,
ERCC2, ERCC4, MGMT and OGG1 (Zienolddiny et al.,
2006; Hung et al., 2007) and (4) proteins implicated in the
cell cycle and apoptosis, such as CCND1, CHEK2, MDM2,
TP53 and EGF (Hosgood III et al., 2008).
In some populations, a significant association be-
tweengenepolymorphismsandtheriskofLCriskhasbeen
established,whileinotherpopulationsnoassociationshave
been found, probably because of the low frequency of
polymorphisms. For example, the CYP1A1 rs1048943
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Research Article(Ile462Val) polymorphism is associated with a risk of LC
in Asian Korean, Chinese and Japanese populations (Lee et
al., 2008) and in Chilean (Quinoñes et al., 2001), Mexican
(Gallegos-Arreola et al., 2008) and Afro-American (Taioli
et al., 1998) populations, whereas this association has not
been confirmed in American and European Caucasians,
possibly because the frequency of the CYP1A1 rs1048943
polymorphism in these populations is < 2% (Hung et al.,
2003). In contrast, the GSTM1 deletion polymorphism,
which has a frequency of 0.35-0.58 in Asians, European
andAmericanCaucasiansandAfricans(Mohretal.,2003),
is significantly associated with LC in Caucasians (Hung et
al., 2003) and Asians (Lee et al., 2008). ERCC2 rs1799793
(Asp399Asn), ERCC2 rs13181 (Lys751Asn) and MGMT
rs12917 (Leu84Phe) polymorphisms show no consistent
association with LC in different populations (Kiyohara and
Yoshimasu, 2007). However, XRCC1 rs3213245 (-77
T > C) was associated with a risk of LC in three case-
control studies and ERCC2 rs13181 was associated with a
risk of LC in a meta-analysis study of 18 case-control re-
ports (Vineis et al., 2009).
Since these polymorphisms modify the functionality
of the encoded proteins it has been suggested that polymor-
phic variants may alter the metabolic and detoxification
pathways of carcinogenic compounds, thereby predispos-
ing the individual bearing these polymorphisms to develop
cancer (Nebert and Dalton, 2006). Indeed, polymorphisms
in specific genes can modulate the formation of DNA-
carcinogenadducts(Ketelslegersetal.,2006)whichfavors
the generation of mutations leading to LC, particularly in
smokers (Lodovici et al., 2004).
Recently, a polygenic cancer model was proposed
that considers the genetic susceptibility to cancer as a
global mechanism, with the susceptibility being defined by
low risk alleles in multiple candidate genes (Pharoah et al.,
2002; Dong et al., 2008). Susceptibility to LC may be
caused by low penetrance genes (low risk) with high fre-
quencies in the general population (Kiyohara et al., 2007).
Inthiscontext,susceptibilitytoLCisdeterminedbyacom-
bination of multiple low risk alleles in an individual, with
each allele contributing only slightly to the overall cancer
risk, as proposed by Fletcher and Houlston (2010) in their
polygenic additive model. This model, which allows the
identificationofhighriskindividuals,maybeusefulinpre-
venting LC in the early stages, thereby significantly reduc-
ing LC-related mortality and the costs associated with the
diagnosis and treatment of this disease.
The first step in any study of molecular epidemiology
in which ethnicity plays an important role is the character-
izationofthegeneralhealthypopulationsincethiswillpro-
vide the benchmark for further analysis. In this study, we
investigated 16 polymorphisms in 12 low penetrance genes
inahealthyMexicanMestizopopulation.Thesegenescode
for proteins involved in the metabolic pathways of some
environmental and tobacco smoke carcinogens, with their
polymorphismsreportedlyproducingfunctionalalterations
that are associated with the risk of developing LC. The as-
sociationbetweenthesepolymorphismsandtheriskofcan-
cer was assessed using the polygenic additive model for
cancer.
Materials and Methods
Subjects
The research protocol was approved by the Commit-
tee of Bioethics of the Instituto de Investigaciones Biomé-
dicas of the Universidad Nacional Autónoma de México,
and the Hospital “20 de Noviembre” ISSSTE gave permis-
siontousethebuffycoatofbloodbanksamplesasasource
of DNA. The study included 382 unrelated, healthy Mexi-
can Mestizo individuals whose parents and grandparents
were born in Mexico. After providing informed consent,
the subjects answered a questionnaire that included infor-
mation on their age, gender, smoking status and lifestyle.
Polymorphism analysis
Genomic DNA was obtained from blood samples by
phenol-chloroform extraction and ethanol precipitation
(Sambrook et al., 1987). The presence of the AhR
rs2066853 (Arg554Lys) polymorphism was determined by
using the TaqMan probe C_11170747_20 from Applied
Biosystems, according to the manufacturer’s recommenda-
tions. Restriction fragment length polymorphism (RFLP)
analysis was used to assess the following polymorphisms:
CYP1A1 rs4646903 (6235T > C) and CYP1A1 rs1800031
(5639T > C) (Kawajiri, 1999), CYP1A1 rs1048943
(Ile462Val) and CYP1A1 rs1799814 (Thr461Asn)
(Cascorbi et al., 1996), CYP2E1 rs2031920 (-1053C > T)
(Morita et al., 1997), EPHX1 rs1051740 (Tyr113His) and
EPHX1 rs2234922 (His139Arg) (Smith and Harrison,
1997), GSTPI rs947894 (Ile105Val) (Harries et al., 1997),
XRCC1 rs25487 (Arg399Gln) (Abdel-Rahman and
El-Zein, 2000), ERCC2 rs13181 (Lys751Gln) (Lunn et al.,
2000),MGMTrs12917(Leu84Phe)(Courtneyetal.,2005),
CCND1 rs603965 (870G > A) (Wang et al., 2002), and
TP53 rs1042522 (Arg72Pro) (Irarrázabal et al., 2003).
PolymorphismsofGSTT1nullandGSTM1nullweredeter-
minedbymultiplexPCRusingapreviouslyreportedproto-
col (Abdel-Rahman et al., 1996).
Statistical analyses
The statistical package GenePop version 4.0.10
(http://genepop.curtin.edu.au) was used to assess whether
the genotypes of each gene were in Hardy-Weinberg equi-
librium and to determine the degree of linkage between the
EPHX1 and CYP1A1 gene polymorphisms. Conglomerate
andhierarchicalclusteringanalyseswereusedtodetermine
the genetic variability of the sample. The estimated cancer
risk and the genotypic and allelic frequencies were deter-
mined using the statistical package JMP version 8.
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Of the 382 Mexican Mestizo individuals studied,
29% were women and 71% were men. The age range was
between 18 and 80 years (mean age: 39.2  12.1 for men
and 41.5  13.1 for women) and 48% of the population
were smokers.
The following polymorphisms were studied in candi-
date genes: AhR rs2066853, CYP1A1 rs4646903, CYP1A1
rs1048943, CYP1A1 rs1800031, CYP1A1 rs1799814,
CYP2E1 rs2031920, EPHX1 rs1051740, EPHX1
rs2234922, GSTM1 null, GSTT1 null, GSTPI rs947894,
XRCC1 rs25487, ERCC2 rs13181, MGMT rs12917,
CCND1 rs603965 and TP53 rs1042522. The genotypic and
allelic frequencies of these polymorphisms are shown in
Table 1. All genotypes were in Hardy-Weinberg equilib-
rium. GSTM1 and GSTT1 were not analyzed for Hardy-
Weinberg equilibrium because the methodology did not al-
lowdiscriminationbetweenheterozygousandhomozygous
positive genotypes.
Polymorphisms in the same gene may have synergis-
tic or antagonistic effects, as in the case of CYP1A1 and
epoxide hydrolase 1. This is functionally significant be-
cause CYP1A1 acts in association with EPHX1 to convert
polyaromatic hydrocarbons to highly toxic, mutagenic and
carcinogenic epoxides.
Linkage analysis of four CYP1A1 and two EPHX1
polymorphisms showed that the CYP1A1 rs1799814 and
CYP1A1 rs1800031 genotypes were linked in all cases,
with a probability of 1 (p < 0.001), whereas CYP1A1
rs4646903 and CYP1A1 rs1048943 polymorphisms were
not linked, with a probability of 0 (p < 0.001). EPHX1
rs1051740 and EPHX1 rs2234922 were linked, with a
probability of 0.03254 (p = 0.0025). Combinations of
CYP1A1 polymorphisms are shown in Table 2.
Conglomerate analysis was used to determine the ge-
netic variability and the possible grouping of the individu-
als analyzed. We identified six groups that clustered
according to their genetic characteristics, although there
was considerable heterogeneity (Figure 1). Additionally,
hierarchical cluster analysis of the genotypes showed that
CYP1A1 rs1800031 and CYP1A1 rs1799814 polymor-
phisms clustered together, whereas CYP1A1 rs4646903
and CYP1A1 rs1048943 were close to each other but clus-
tered separately (Figure 2). The EPHX1 rs1051740 and
EPHX1 rs2234922 polymorphisms were widely separated,
as also indicated by linkage analysis.
Todeterminethetheoreticallevelsofsusceptibilityto
LC, a risk matrix was generated using a log-additive model
in which a value of 0 was assigned to homozygous geno-
types that produced no risk, 1 to heterozygous genotypes
(medium risk) and 2 to homozygous genotypes that pro-
duced changes in the activity of the protein, considered to
be high risk. The individual calculated risk values (iCRVs)
were determined by adding the values of the log-additive
model to each locus. The iCRVs ranged from 1 to 16, al-
though there was a marked decrease in individuals with
iCRV  5 and  12 (Figure 3).
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Table 1 - Frequency of lung cancer risk polymorphisms among healthy Mexican Mestizos.
Gene (rs) Genotype frequency, n (%) Allelic frequency
Mutant allele n Wild type homozygous Heterozygous Mutant homozygous p
b q
c
Ahr (2066853) Lys 370 260 (70.2) 107 (29) 3 (0.8) 0.85 0.15
CYP1A1 (4646903) C 382 97 (25.4) 193 (50.5) 92 (24.1) 0.51 0.49
CYP1A1 (1048943) Val 382 86 (22.5) 176 (46.1) 120 (31.4) 0.45 0.55
CYP1A1 (1800031) C 382 378 (99) 4 (1) 0 0.994 0.006
CYP1A1 (1799814) Asn 382 339 (88.7) 39 (10.3) 4 (1) 0.946 0.054
CYP2E1 (2031920) T 382 272 (71.2) 102 (26.7) 8 (2.1) 0.85 0.15
EPHX1 (1051740) His 382 121 (31.7) 133 (34.8) 128 (33.5) 0.49 0.51
EPHX1 (2234922) Arg 382 323 (84.6) 55 (14.4) 4 (1) 0.92 0.08
GSTPI (947894) Val 382 102 (26.7) 192 (50.3) 88 (23) 0.52 0.48
GSTM1 (deletion) Null 382 239 (62.6) ND
a 143 (37.4) 0.63 0.37
GSTT1 (deletion) Null 382 324 (84.8) ND
a 58 (15.2) 0.85 0.15
XRCC1 (25487) Gln 382 211 (55.2) 147 (38.5) 24 (6.3) 0.75 0.25
ERCC2 (13181) Gln 382 258 (67.5) 98 (25.7) 26 (6.8) 0.8 0.2
MGMT (12917) Phe 382 205 (53.7) 125 (32.7) 52 (13.6) 0.7 0.3
CCND1 (603965) A 382 162 (42.4) 156 (40.8) 64 (16.8) 0.63 0.37
TP53 (1042522) Pro 382 163 (42.7) 159 (41.6) 60 (15.7) 0.64 0.36
aNot determined.
bp – wild type allele.
cq – mutant allele.Discussion
Cancer is a polygenic disease, the risk of which may
be related to the presence of low-penetrance genes that
have additive effects. In this study, we examined the fre-
quency of some polymorphisms possibly related to the risk
of developing lung cancer in a sample of healthy Mexican
Mestizos. These polymorphisms may be useful biomarkers
of genetic susceptibility to lung cancer in specific popula-
tions.
Wehavepreviouslyreportedonthehighfrequencyof
the CYP1A1 rs1048943 polymorphism in Mexican Mes-
tizos (Pérez-Morales et al., 2008), a polymorphism that is
highly represented in Amerindians (Kvitko et al., 2000). In
some populations, the CYP1A1 rs1048943 polymorphism
has been associated with a risk of LC (Quinoñes et al.,
2001; Lee et al., 2008; Shah et al., 2008), although not all
studieshavefoundsuchanassociation,especiallywhenthe
frequencyofthispolymorphismisverylow,asinEuropean
and American Caucasian populations (Hung et al., 2003).
However, in some populations the CYP1A1 rs1048943
polymorphism has a significant influence on the risk of de-
veloping LC because of the additive effect of other poly-
morphisms.
Although the CYP1A1 rs1799814 and CYP1A1
rs1800031 genotypes were found to be linked, the linkage
analysis may have been affected by the high frequencies of
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Table 2 - Linkage analysis of the CYP1A1 and EPHX1 loci.
Gene Locus 1
genotype
Locus 2
genotype
Linkage probability p Switches
rs1048943
Val/Val
rs4646903
C/C 0 < 0.001 86515
rs1048943
Val/Val
rs1800031
C/C 0.269010 0.003075 53643
CYP1A1 rs1048943
Val/Val
rs1799814
Asn/Asn 0.236880 0.006550 62708
rs1800031
C/C
rs4646903
C/C 0.811290 0.001748 53666
rs1799814
Asn/Asn
rs4646903
C/C 0.196950 0.005966 62546
rs1799814
Asn/Asn
rs1800031
C/C 1 < 0.001 14571
EPHX1 rs1051740
His/His
rs2234922
Arg/Arg 0.03254 0.002541 64999
Figure1-Conglomerateanalysisshowingthegeneticheterogeneityofthepopulationstudiedinthiswork.C–clusternumber,n–numberofindividuals
per cluster and P – the probability of each cluster. Only under-represented genotypes are shown.the wild type allele at these loci in our population. On the
other hand, in contrast to a previous report (Hayashi et al.,
1991), the CYP1A1 rs4646903 and CYP1A1 rs1048943
polymorphisms were not linked. This observation is func-
tionally significant because the CYP1A1 rs1048943 poly-
morphism increases the activity of cytochrome CYP1A1,
resulting in a more efficient generation of reactive metabo-
lites, whereas the CYP1A1 rs4646903 polymorphism in-
creasesthelevelsofCYP1A1mRNA.Hence,thecombina-
tion of these alleles could increase the risk of LC (Yoon et
al., 2008). Some studies have associated CYP1A1
rs1799814 polymorphism with a risk of LC (Gallegos-
Arreolaetal.,2008),whereasCYP1A1rs1800031isreport-
edly specific for African populations but is not associated
with a risk of LC (Taioli et al., 1998).
The proportion of the population carrying both the
EPHX1 rs1051740 and EPHX1 rs2234922 alleles was very
small. In these individuals, the allele EPHX1 rs1051740
Tyr113 apparently offered no protection against LC, in
contrast to previous observations (Voho et al., 2006). On
the other hand, the EPHX1 rs2234922 139Arg variant in-
creases the activity of the encoded enzyme (Hassett et al.,
1994), which could suppress the low activity of the EPHX1
113His variant (Salam et al., 2007). For example, an indi-
vidual with the CYP1A1 rs4646903, CYP1A1 rs1048943,
EPHX1 rs1051740 and EPHX1 rs2234922 polymorphisms
will produce reactive metabolites more efficiently and con-
sequently have a higher risk of developing LC.
A conglomerate analysis of the genetic variability of
the population studied here revealed six groups that clus-
tered according to their genetic characteristics (Figure 1).
In clusters 2 and 4, the polymorphism CYP1A1 rs1800031
was quite separate from the rest of the genotypes, although
it should be noted that these two groups consisted of only
two subjects each such that the probability of finding indi-
viduals belonging to these clusters in a given population is
very low. In clusters 2, 3, 4 and 5, AhR rs2066853, EPHX1
rs2234922, GSTT1 null, ERCC2 rs13181, and CYP1A1
rs1799814 were over-represented with respect to the other
polymorphisms analyzed, but the number of individuals
was smaller than in clusters 1 and 6; there was no predomi-
nant genotype in the latter two clusters because of the com-
bination of polymorphic alleles at each locus in each indi-
vidual.Despitethisclustering,ourfindingsindicatethatthe
population studied was highly heterogenous, as is charac-
teristic of Mexican Mestizos.
Hierarchical cluster analysis showed that the genes
were grouped according to their frequency. This analysis
also revealed that CYP1A1 rs1800031 and CYP1A1
rs1799814occurredtogether,inagreementwiththelinkage
analysis, whereas CYP1A1 rs4646903 and CYP1A1
rs1048943 were found together in some individuals but
were not linked (as indicated by the separation of their
branches). Overall, this analysis showed that a portion of
the population carried both risk alleles, although they were
not linked. However, we have not determined whether
these polymorphisms are in a cis or trans position, which
could affect the linkage results.
Our analysis revealed individuals with a high suscep-
tibility to LC based on the presence of risk genotypes, al-
though different combinations of risk genotypes may
confer varying degrees of susceptibility when combined
with other components, such as environmental factors.
If the risk of developing LC is attributed to the inter-
action of several low-penetrance genes that exert an addi-
tive effect then we should be able to detect individuals with
a high number of risk alleles and a greater genetic suscepti-
bility to LC. We estimated the levels of susceptibility and
found that the iCRV ranged from 1 to 16; there was a
marked decrease in the susceptibility to LC among individ-
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Figure 2 - Hierarchical cluster analysis of the different genotypes based
on the genetic characteristics of healthy Mexican Mestizos. r = 0.94939.
*Allelic frequencies of the polymorphic genotypes.
Figure 3 - Estimated risk of lung cancer in a healthy Mexican Mestizo
population. The arrow indicates the 85th percentile.uals with an iCRV  12. Application of the polygenic
model (Fletcher and Houlston, 2010) (Figure 3) yielded a
normal distribution of risk alleles in which low and high
riskindividualsoccurredattheextremesofthedistribution.
Theoretically,high-riskindividualsshouldbemoresuscep-
tibletoLC,butonecannotexcludetheimportantroleofge-
notype x environmental interactions to which individuals
are exposed.
Based on the polygenic model of cancer, which takes
into consideration the additive effect of multiple risk al-
leles, the high risk genotypes identified in this study in-
cluded genes involved in phase I and II metabolism, DNA
repair, oxidative stress and cell cycle regulation. All of
these gene groups need to be considered when analyzing
the efficiency of reactive metabolite generation, DNA-
adduct repair, damage persistence and the cellular response
tocyclearrestorapoptosis.However,asshownhere,onlya
small minority of individuals actually possess a large num-
ber of risk alleles. Although studies of other populations
have associated specific polymorphisms with a risk of LC,
these relationships have not always been confirmed, possi-
bly because of the pleiotropic or epistatic effects of one ge-
notype on another within the same population.
Since LC is a multifactorial, polygenic disease, it is
incorrect to attribute the susceptibility to LC to a single
gene or group of related genes. In this context, determining
the genetic background of a healthy population, such as
done here for a Mexican Mestizo population, can provide a
sound basis for subsequent studies on the association be-
tweentheseriskgenotypesandLC.Insuchcases,theiCRV
should be higher in patients than in the healthy controls.
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